VRS
ADVM

Virginia Retirement Systems’s Adverum Biotechnologies ADVM Stock Holding History

Virginia Retirement Systems’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,280
Closed -$93K – 1098
2021
Q3 		$93K Buy
4,280
+800
+23% +$20.4K ﹤0.01% 972
2021
Q2 		$122K Buy
+3,480
New +$187K ﹤0.01% 1000

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Virginia Retirement Systems's ADVM Position: Q4 2021 in Review

Virginia Retirement Systems sold out of Adverum Biotechnologies (ADVM) in Q4 2021, closing a stake of 4,280 shares — an estimated $93K sold.

Virginia Retirement Systems first reported a position in ADVM in Q2 2021 and held it in 2 quarters. The position peaked at $122K in Q2 2021. 98 funds tracked by Wall St. Rank hold ADVM as of Q4 2021.

  • Virginia Retirement Systems reported no remaining Adverum Biotechnologies position as of Q4 2021 after selling out during the quarter.
  • Virginia Retirement Systems sold 4,280 Adverum Biotechnologies shares in Q4 2021, an estimated $93K.
  • Virginia Retirement Systems first reported a position in Adverum Biotechnologies in Q2 2021 and held it in 2 quarters.
  • Virginia Retirement Systems's Adverum Biotechnologies position peaked at $122K in Q2 2021.
  • 98 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2021.

Based on Virginia Retirement Systems's 13F filing for Q4 2021, filed 3 Feb 2022.